Fig. 3. Proportion of patients who answered more than 3 points (“moderate or more of improvement”) of subject global assessment (SGA) for at least 1 week of the 2-week treatment period (A), for at least 1 of the 3 weeks of treatment and follow-up period (B), and proportion of patients who answered more than 3 points of SGA at each week (C) in the phloroglucinol and placebo groups.
© J Neurogastroenterol Motil
